期刊文献+

慢病毒介导shRNA沉默survivin基因对鸡胚绒毛尿囊膜子宫内膜异位症模型的影响 被引量:5

Effect of lentiviral vector-mediated short hairpin RNA targeting survivin against endometriosis-like lesions in chick embryo chorioallantoic membrane
下载PDF
导出
摘要 目的研究慢病毒介导生存素基因特异性短发夹状RNA(shRNA)对子宫内膜异位症异位内膜生长及新生血管形成的影响。方法建立鸡胚绒毛尿囊膜(CAM)子宫内膜异位症模型,随机分成单纯接种组、shRNA慢病毒组、空载慢病毒组和空白载体组,每组30只。通过Image-proplus软件测量新生血管面积与鸡胚尿囊膜面积比(VA/CAM)评价沉默survivin基因对CAM血管生成的影响,TUNEL检测异位内膜细胞凋亡,组织病理学观察异位内膜病灶生长行为。结果 shRNA慢病毒处理组种植内膜存活率最低,该组VA/CAM明显低于单纯接种组、空载慢病毒组和空白载体组(P<0.001),后3组间比较无显著性差异(P>0.05)。shRNA慢病毒处理组种植内膜细胞凋亡率明显高于其他3组(P<0.05),另3组间比较无显著性差异(P>0.05)。shRNA慢病毒处理组病灶在光镜下可见腺体结构不完整,间质伴有不同程度的坏死。结论慢病毒介导survivin基因特异性shRNA能够显著抑制人子宫内膜异位症种植CAM模型的新生血管形成,抑制子宫内膜在CAM上的种植生长。 Objective To investigate the inhibitory effect of lentiviral vector-mediated short hairpin RNA targeting survivin (LV-survivin shRNA) on angiogenesis and growth of endometriosis-like lesions in chick en embryo chorioallantoic membrane. Methods Eutopic endometrium from women with endometriosis was transplanted onto the non-vascular region of (CAM), where LV-survivin shRNA was delivered subsequently. The angiogenesis and the growth of endometriosis-like lesions in the CAM model were evaluated. Results The angiogenesis and formation of endometriosis-like lesions were significantly suppressed in the CAM model by treatment with LV-survivin shRNA in comparison with those in the untreated CAM models and models treated with empty LV or DMEM (P〈0.001). LV-survivin shRNA also caused a significantly higher cell apoptotic rate in the endometriosis-like lesions than the other treatments (P〈0.001) and induced necrosis in the lesions. Conclusion LV-survivin shRNA can effectively inhibit angiogenesis induced by the eutopic endometrium and markedly suppress the formation of endometriosis-like lesions in the CAM model.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2012年第7期995-999,共5页 Journal of Southern Medical University
基金 广东省科技计划项目(2011B031800089)
关键词 生存素 短发夹状RNA 子宫内膜异位症 慢病毒 鸡胚绒毛尿囊膜 survivin short hairpin RNA endometriosis lentivirus chicken embryo chorioallantoic membrane
  • 相关文献

参考文献15

二级参考文献41

  • 1王芳,何援利,刘木彪.核转录因子-κB在子宫内膜异位症中的表达及其意义[J].诊断病理学杂志,2005,12(2):137-139. 被引量:8
  • 2李震东,马清涌,徐军,李明.Fas和FasL在急性胰腺炎中的共表达及其与凋亡的关系[J].南方医科大学学报,2006,26(1):25-29. 被引量:17
  • 3Giudice LC, Tazuke SI, Swiersz LT. Status of current research on endometriosis[J ]. J Reprod Med, 1998, 43(3): 252-62.
  • 4Barnes P J, Karin M. Nuclear factor- B: a pivotal transcription factor in chronic inflammatory diseases[J]. N Engl J Med, 1997, 336(15): 1066-71.
  • 5Mclaren J. Vascular endothelial growth factor and endometriotic angiogenesis [ J ]. Hum Reprod Update, 2000, 6(1 ): 44-5.
  • 6Karin M, Lin A. NF-kappaB at the crossroads of life and death [ J ]. Nat Immunol, 2002, 3(3): 221-7.
  • 7Sarkar FH, Li Y. NK-kappaB: a potential target for cancer chemoprevention and therapy [J]. Front Biosci, 2008, 13 (1):2950-9.
  • 8Gonzalez-Ramos R, Van Langendonckt A, Defrere S, et al. Agent blocking the nuclear factor-kappaB pathway are effective inhibitors ofendometriosis in an in vivo experimental model [J]. Gynecol Obstet Invest, 2008, 65(3): 174-86.
  • 9Nasu K, Nishida M, Ueda T, et al. Application of the nuclear factor- B inhibitor BAY 11-7085 for the treatment ofendometriosis: an in vitro study [J]. Am J Physiol Endocrinol Metab, 2007, 293 (1): E16-23.
  • 10Schmidt J,David W,Rattuer A,et al.A better model of acute panereatitis for evaluating therapy[J].Ann Surg,1992,215(1):44-56.

共引文献28

同被引文献45

  • 1鲁德玕,姬晓青.非小细胞肺癌中survivin及bcl-xl基因蛋白的表达及其相关性研究[J].中国实用内科杂志,2006,26(10):1523-1525. 被引量:7
  • 2王芳,何援利,罗敏,宗利丽,赵汝珠,刘木彪.子宫内膜异位症核转录因子和血管内皮生长因子表达与预后的关系[J].西北国防医学杂志,2007,28(2):116-119. 被引量:6
  • 3Harada T, Taniguchi F, Izawa M, et al. Apoptosis and en- dometriosis [ J]. Front Biosci ,2007,12:3140-3151.
  • 4May K, Becker CM. Endometriosis and angiogenesis [ J ]. Minerva Gineco1,2008,60 ( 3 ) : 245-254.
  • 5Caldas H, Fangusaro JR, Boue DR, et al. Dissecting the role of endothelial SURVIVIN DehaEx3 in angiogenesis [ J]. Blood,2007,109(4) : 1479-1489.
  • 6Fujino K, Ueda M, Takehara M, et al. Transcriptional ex- pression of survivin and its splice variants in endometriosis [ J ]. Mol Hum Reprod, 2006,12 ( 6 ) :383-388.
  • 7Goteri G, Lucarini G, Pieramici T, et al. Endothelial cell survivin is involved in the growth of ovarian endometriotic cysts[J]. Anticancer Res,2005,25 (6B) :4313-4318.
  • 8Watanabe A,Taniguchi F, Izawa M, et al. The role of sur- vivin in the resistance of endometriotic stromal cells to drug-induced apoptosis [ J ]. Hum Reprod, 2009,24 ( 12 ) : 3172-3179.
  • 9Azrak RG, Frank CL, Ghadersohi A, et al. Silencing sur- vivin results in synergy between methylseleninic acid and paclitaxel against skov3 ovarian cancer ceils [ J ]. Cancer Biol Ther,2008,7 (12) :1901-1908.
  • 10Roca H, Varsos ZS, Mizutani K, et al. CCL2, survivin and autophagy:new links with implications in human cancer [ J ]. Autophagy, 2008,4 ( 7 ): 969 -971.

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部